Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM) Conference

Mehta, M, Wang, M, Aldape, K et al. (2011). Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM) . EUROPEAN JOURNAL OF CANCER, 47 10-10. 10.1016/S0959-8049(11)70117-4

International Collaboration

cited authors

  • Mehta, M; Wang, M; Aldape, K; Sulman, E; Stupp, R; Jaeckle, K; Blumenthal, D; Erridge, S; Curran, W; Gilbert, M

sustainable development goals

authors

publication date

  • September 1, 2011

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCI LTD

start page

  • 10

end page

  • 10

volume

  • 47